Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision
- 25 July 2006
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (30) , 11405-11410
- https://doi.org/10.1073/pnas.0506112103
Abstract
Transparency of the cornea, the window of the eye, is a prerequisite for vision. Angiogenesis into the normally avascular cornea is incompatible with good vision and, therefore, the cornea is one of the few tissues in the human body where avascularity is actively maintained. Here, we provide evidence for a critical mechanism contributing to corneal avascularity. VEGF receptor 3, normally present on lymphatic and proliferating blood vascular endothelium, is strongly constitutively expressed by corneal epithelium and is mechanistically responsible for suppressing inflammatory corneal angiogenesis.Keywords
This publication has 31 references indexed in Scilit:
- Flt-1 Intraceptors Inhibit Hypoxia-Induced VEGF Expression In Vitro and Corneal Neovascularization In VivoInvestigative Opthalmology & Visual Science, 2005
- Complete and Specific Inhibition of Adult Lymphatic Regeneration by a Novel VEGFR-3 Neutralizing AntibodyJNCI Journal of the National Cancer Institute, 2005
- Lymphangiogenesis and tumor metastasisCell and tissue research, 2003
- VEGF-D Is the Strongest Angiogenic and Lymphangiogenic Effector Among VEGFs Delivered Into Skeletal Muscle via AdenovirusesCirculation Research, 2003
- Corneal LymphangiogenesisCornea, 2003
- Inhibition of Angiogenesis by Adenovirus-Mediated sFlt-1 Expression in a Rat Model of Corneal NeovascularizationHuman Gene Therapy, 2001
- Proinflammatory Cytokines Regulate Expression of the Lymphatic Endothelial Mitogen Vascular Endothelial Growth Factor-CJournal of Biological Chemistry, 1998
- Definition of Two Angiogenic Pathways by Distinct α v IntegrinsScience, 1995
- Novel production of interleukin-1 receptor antagonist peptides in normal human cornea.Journal of Clinical Investigation, 1995
- How the field of controlled-release technology began, and its central role in the development of angiogenesis researchBiomaterials, 1990